INTELLIGENT ULTRASOUND GROUP PLC

Director's Dealing • Apr 24, 2020

National Storage Mechanism | Additional information

RNS Number : 8502K

Intelligent Ultrasound Group PLC

24 April 2020

24 April 2020

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Company" or the "Group")

Grant of Options

Intelligent Ultrasound Group plc (AIM: MED), the ultrasound artificial intelligence (AI) software and simulation company, today announces that Helen Jones, Chief Financial Officer, has been granted options of 1,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at an exercise price of 12 pence per Ordinary Share ("Options").

One third of the Options will vest once the closing mid-market price of the Company's Ordinary Shares reaches an average of at least 25 pence per share for a continuous period of 20 business days; one third of the Options will vest once the closing mid-market price of the Company's Ordinary Shares reaches an average of at least 37.5 pence per share for a continuous period of 20 business days and the final third of the Options will vest once the closing mid-market price of the Company's Ordinary Shares reaches an average of at least 50 pence per share for a continuous period of 20 business days. Any unexercised options will lapse on 24 April 2030.

Enquiries:

Intelligent Ultrasound Group plc			www.intelligentultrasound.com
Stuart Gall, CEO  Helen Jones,  CFO			Tel: +44 (0)29 2075 6534
Cenkos Securities plc - Nominated Advisor and broker			Tel:  +44 (0)20 7397 8900
Giles Balleny / Cameron MacRitchie (Corporate Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR	Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy / Paul McManus		Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: MED) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market.

Based in Cardiff and Oxford in the UK, Atlanta in the US and with representation in Beijing in Asia, the Group operates two divisions:

Clinical AI Division

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav which uses machine-learning based algorithms to automatically identify and grade ultrasound images to provide scan assessment and audit of protocol-based ultrasound scanning; and  AnatomyGuide, which aims to simplify ultrasound-guided needling by providing the user with real-time AI-based needle guidance software for a range of medical procedures.

Simulation Division

Focusses on hi-fidelity ultrasound education and training through simulation.  Its three main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator and the BodyWorks Eve Point of Care and Emergency Medicine training simulator. To date over 800 simulators have been sold to almost 500 medical institutions around the world.

www.intelligentultrasound.com 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Helen Jones
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Full name of the entity	Intelligent Ultrasound Group plc
b)	Legal entity identifier code	213800K4ZVWL4ZYQAZ70
4	Details of the transaction(s)
a)	Description of the financial instrument, type of instrument	Options over ordinary shares in Intelligent Ultrasound Group plc with a nominal value of 1 pence each
b)	Identification Code	ISIN: GB00BN791Q39
c)	Nature of the transaction	Grant of options over Ordinary Shares
d)	Currency	GBP - British pound
e)	Price(s) and Volume(s)	Price - 12 pence Volume - 1,000,000
f)	Aggregated information -      Price -      Volume -      Total	N/A
g)	Date of transaction	24 April 2020
h)	Place of transaction	Off market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHKZGZDFDZGGZM